<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">88206</article-id><article-id pub-id-type="doi">10.7554/eLife.88206</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-312974"><name><surname>Castano</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-312975"><name><surname>Silvestre</surname><given-names>Margaux</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1377-477X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="other" rid="par-10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-312976"><name><surname>Wells</surname><given-names>Carrow I</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4799-6792</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-312977"><name><surname>Sanderson</surname><given-names>Jennifer L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-312978"><name><surname>Ferrer</surname><given-names>Carla A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-312979"><name><surname>Ong</surname><given-names>Han Wee</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-312980"><name><surname>Lang</surname><given-names>Yi</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-312981"><name><surname>Richardson</surname><given-names>William</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-312982"><name><surname>Silvaroli</surname><given-names>Josie A</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-312983"><name><surname>Bashore</surname><given-names>Frances M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4241-9873</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-312984"><name><surname>Smith</surname><given-names>Jeffery L</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2189-0420</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-312985"><name><surname>Genereux</surname><given-names>Isabelle M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-312986"><name><surname>Dempster</surname><given-names>Kelvin</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0009-0750-0175</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-312987"><name><surname>Drewry</surname><given-names>David H</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-312988"><name><surname>Pabla</surname><given-names>Navlot S</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9408-0539</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-312989"><name><surname>Bullock</surname><given-names>Alex N</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-223171"><name><surname>Benke</surname><given-names>Tim A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6969-5061</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-201819"><name><surname>Ultanir</surname><given-names>Sila</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5745-3957</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="other" rid="par-10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-312990"><name><surname>Axtman</surname><given-names>Alison D</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution content-type="dept">Department of Pharmacology</institution>, <institution>University of Colorado Anschutz Medical Campus</institution>, <addr-line><named-content content-type="city">Aurora</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Kinases and Brain Development Laboratory</institution>, <institution>The Francis Crick Institute</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Structural Genomics Consortium</institution>, <institution>University of North Carolina at Chapel Hill</institution>, <addr-line><named-content content-type="city">Chapel Hill</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Nuffield Department of Medicine</institution>, <institution>University of Oxford</institution>, <addr-line><named-content content-type="city">Oxford</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff5"><institution content-type="dept">Division of Pharmaceutics and Pharmacology</institution>, <institution>The Ohio State University</institution>, <addr-line><named-content content-type="city">Columbus</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Division of Pharmaceutics and Pharmacolog</institution>, <institution>The Ohio State University</institution>, <addr-line><named-content content-type="city">Columbu</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Department of Pediatrics</institution>, <institution>University of Colorado Anschutz Medical Campus</institution>, <addr-line><named-content content-type="city">Aurora</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-296212"><name><surname>Talevi</surname><given-names>Alan</given-names></name><role>Reviewing editor</role><aff><institution>National University of La Plata</institution>, <country>Argentina</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>tim.benke@cuanschutz.edu</email> (TB);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>sila.ultanir@crick.ac.uk</email> (SU);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>Alison.Axtman@unc.edu</email> (AA);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>25</day><month>07</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e88206</elocation-id><history><date date-type="received"><day>29</day><month>03</month><year>2023</year></date><date date-type="accepted"><day>24</day><month>07</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Castano et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Castano et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-88206-v1.pdf"/><abstract><p>Pathological loss-of-function mutations in cyclin-dependent kinase-like 5 (<italic>CDKL5</italic>) cause CDKL5 deficiency disorder (CDD), a rare and severe neurodevelopmental disorder associated with severe and medically refractory early-life epilepsy, motor, cognitive, visual and autonomic disturbances in the absence of any structural brain pathology. Analysis of genetic variants in CDD have indicated that CDKL5 kinase function is central to disease pathology. <italic>CDKL5</italic> encodes a serine-threonine kinase with significant homology to GSK3b, which has also been linked to synaptic function. Further, <italic>Cdkl5</italic> knock-out rodents have increased GSK3b activity and often increased long-term potentiation (LTP). Thus, development of a specific CDKL5 inhibitor must be careful to exclude cross-talk with GSK3b activity. We synthesized and characterized specific, high-affinity inhibitors of CDKL5 that do not have detectable activity for GSK3b. These compounds are very soluble in water but blood-brain barrier penetration is low. In rat hippocampal brain slices, acute inhibition of CDKL5 selectively reduces post-synaptic function of AMPA-type glutamate receptors in a dose-dependent manner. Acute inhibition of CDKL5 reduces hippocampal LTP. These studies provide new tools and insights into the role of CDKL5 as a newly appreciated, key kinase necessary for synaptic plasticity. Comparisons to rodent knock-out studies suggest that compensatory changes have limited the understanding of the roles of CDKL5 in synaptic physiology, plasticity and human neuropathology.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Rat</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>NS112770</award-id><principal-award-recipient><name><surname>Castano</surname><given-names>Anna</given-names></name><name><surname>Silvestre</surname><given-names>Margaux</given-names></name><name><surname>Wells</surname><given-names>Carrow I</given-names></name><name><surname>Sanderson</surname><given-names>Jennifer L</given-names></name><name><surname>Ferrer</surname><given-names>Carla A</given-names></name><name><surname>Ong</surname><given-names>Han Wee</given-names></name><name><surname>Lang</surname><given-names>Yi</given-names></name><name><surname>Richardson</surname><given-names>William</given-names></name><name><surname>Silvaroli</surname><given-names>Josie A</given-names></name><name><surname>Bashore</surname><given-names>Frances M</given-names></name><name><surname>Smith</surname><given-names>Jeffery L</given-names></name><name><surname>Genereux</surname><given-names>Isabelle M</given-names></name><name><surname>Dempster</surname><given-names>Kelvin</given-names></name><name><surname>Drewry</surname><given-names>David H</given-names></name><name><surname>Pabla</surname><given-names>Navlot S</given-names></name><name><surname>Bullock</surname><given-names>Alex N</given-names></name><name><surname>Benke</surname><given-names>Tim A</given-names></name><name><surname>Ultanir</surname><given-names>Sila</given-names></name><name><surname>Axtman</surname><given-names>Alison D</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100018252</institution-id><institution>LouLou Foundation</institution></institution-wrap></funding-source><award-id>11015</award-id><principal-award-recipient><name><surname>Silvestre</surname><given-names>Margaux</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Children's Hospital Colorado Foundation</institution></institution-wrap></funding-source><award-id>Ponzio Family Chair in Neuroscience Research</award-id><principal-award-recipient><name><surname>Castano</surname><given-names>Anna</given-names></name><name><surname>Sanderson</surname><given-names>Jennifer L</given-names></name><name><surname>Benke</surname><given-names>Tim A</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100023921</institution-id><institution>Structural Genomics Consortium</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Wells</surname><given-names>Carrow I</given-names></name><name><surname>Ferrer</surname><given-names>Carla A</given-names></name><name><surname>Ong</surname><given-names>Han Wee</given-names></name><name><surname>Lang</surname><given-names>Yi</given-names></name><name><surname>Bashore</surname><given-names>Frances M</given-names></name><name><surname>Smith</surname><given-names>Jeffery L</given-names></name><name><surname>Genereux</surname><given-names>Isabelle M</given-names></name><name><surname>Drewry</surname><given-names>David H</given-names></name><name><surname>Axtman</surname><given-names>Alison D</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>NC Biotechnology Center Institutional Support Grant</institution></institution-wrap></funding-source><award-id>2018-IDG-1030</award-id><principal-award-recipient><name><surname>Drewry</surname><given-names>David H</given-names></name><name><surname>Axtman</surname><given-names>Alison D</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>U24DK116204</award-id><principal-award-recipient><name><surname>Drewry</surname><given-names>David H</given-names></name><name><surname>Axtman</surname><given-names>Alison D</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R44TR001916</award-id><principal-award-recipient><name><surname>Drewry</surname><given-names>David H</given-names></name><name><surname>Axtman</surname><given-names>Alison D</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>CC2037</award-id><principal-award-recipient><name><surname>Silvestre</surname><given-names>Margaux</given-names></name><name><surname>Ultanir</surname><given-names>Sila</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>CC2037</award-id><principal-award-recipient><name><surname>Silvestre</surname><given-names>Margaux</given-names></name><name><surname>Ultanir</surname><given-names>Sila</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>CC2037</award-id><principal-award-recipient><name><surname>Silvestre</surname><given-names>Margaux</given-names></name><name><surname>Ultanir</surname><given-names>Sila</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Tim A Benke, Consultancy for AveXis, Ovid, GW Pharmaceuticals, International Rett Syndrome Foundation, Takeda, Taysha, CureGRIN, GRIN Therapeutics, Alcyone, Neurogene, and Marinus; Clinical Trials with Acadia, Ovid, GW Pharmaceuticals, Marinus and RSRT; all remuneration has been made to his department..</p></fn><fn fn-type="conflict" id="conf3"><p>Alison D Axtman, Advisor for Proteic Bioscience Inc..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Animals-The Francis Crick Institute (TFCI). Rat handling and housing was performed according to the regulations of the Animal (Scientific Procedures) Act 1986. Animal studies were approved by the Francis Crick Institute ethical committee and performed under U.K. Home Office project license (PPL P5E6B5A4B).Animals-University of Colorado School of Medicine (UC-SOM). All studies conformed to the requirements of the National Institutes of Health Guide for the Care and Use of Laboratory Rats and were approved by the Institutional Animal Care and Use subcommittee of the University of Colorado Anschutz Medical Campus (protocol 00411). Timed-pregnant Sprague Dawley rats (Charles Rivers Labs, Wilmington, MA, USA) gave birth in-house. All rodents were housed in micro-isolator cages with water and chow available ad libitum.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Materials and data availability statement has been provided in the text: Data are available via Dryad (https://doi.org/10.5061/dryad.sn02v6x88). New reagents are available from the senior authors.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Benke TA</collab><collab>et al</collab></person-group><year iso-8601-date="2023">2023</year><source>Data from: Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology</source><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5061/dryad.sn02v6x88">http://dx.doi.org/10.5061/dryad.sn02v6x88</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.sn02v6x88</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-88206-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>